Search results for " Comparative"

showing 10 items of 657 documents

A fuzzy-set analysis of conditions influencing mutual fund performance

2019

Abstract This paper presents an application of fuzzy-set qualitative comparative analysis (fsQCA) to frame the conditions that lead to over- or under-performance of mutual funds. Building upon a considerable library of research on fund returns, the study uses fsQCA to affirm and extend earlier discoveries. Considered here is fund performance relative to Morningstar ratings, features of the funds themselves, as well as characteristics of the fund managers. Results suggest that positive Morningstar and analyst ratings are necessary conditions, on average, for funds to generate value according to the Jensen's alpha ratio. Just over seven percent of the cases imply that funds have attractive Sh…

Mutual fund performanceEconomics and EconometricsManagement fee050208 financeActuarial sciencebusiness.industryQualitative comparative analysisSharpe ratio05 social sciencesInvestment managementFuzzy set analysisLong period0502 economics and businessValue (economics)Businesshealth care economics and organizations050203 business & managementFinanceInternational Review of Economics & Finance
researchProduct

Influences on mutual fund performance: comparing US and Europe using qualitative comparative analysis

2019

This study examines the conditions that lead mutual funds to underperform or outperform competitors. Using fuzzy-set qualitative comparative analysis (fsQCA), we draw upon extensive research on fund returns to affirm and extend earlier discoveries. Fund performance (Morningstar ratings), features of the funds themselves, and characteristics of the fund managers are considered. Positive Morningstar star and analyst ratings are necessary conditions for funds to generate value (measured by Jensen’s alpha). Funds with low management fees and low ongoing fees have attractive Sharpe ratios and high returns. Likewise, large funds with good Morningstar ratings have good Sharpe ratios and returns, o…

Mutual fund performancemorningstar ratingsEconomics and EconometricsfsQCA; fund features; fund manager characteristics; Morningstar ratings; mutual fund performanceQualitative comparative analysisCompetitor analysislcsh:Regional economics. Space in economicslcsh:HD72-88lcsh:HT388mutual fund performancelcsh:Economic growth development planningMicroeconomicsfund manager characteristicsfsqcaBusinessfund featuresEkonomska Istraživanja
researchProduct

Prevalence and severity of anaemia in patients with type 2 diabetic nephropathy and different degrees of chronic renal insufficiency.

2007

<i>Background/Aim:</i> Type 2 diabetes mellitus is the single most common cause of chronic kidney disease (CKD); however its real impact on renal anaemia has not been established. The aim of this study was to evaluate whether onset, severity, and prevalence of anaemia during the course of CKD is different between type 2 diabetic and non-diabetic patients. <i>Methods:</i> We enrolled 281 patients with: (1) type 2 diabetes and no CKD (n = 75); (2) type 2 diabetes plus CKD (n = 106), and (3) CKD without type 2 diabetes (n = 100). According to K/DOQI guidelines, the patients with renal insufficiency (i.e., those with a glomerular filtration rate <60 ml/min) were subgr…

NephrologyMaleglomerulus filtration rateType 2 diabetesurologic and male genital diseasesGastroenterologySeverity of Illness Indexadult; aged; anemia; article; chronic kidney failure; comparative study; controlled study; creatinine clearance; diabetic nephropathy; disease course; disease severity; female; glomerulus filtration rate; hemoglobin blood level; human; kidney failure; kidney function; major clinical study; male; non insulin dependent diabetes mellitus; practice guideline; prevalence; priority journal; risk assessment; Aged; Anemia; Creatinine; Diabetes Mellitus Type 2; Diabetic Nephropathies; Female; Glomerular Filtration Rate; Hemoglobins; Humans; Kidney Failure Chronic; Male; Middle Aged; Prevalence; Severity of Illness Index; Sex DistributionKidney FailureDiabetic nephropathychemistry.chemical_compoundHemoglobinsChronic kidney diseasecreatinine clearancePrevalenceDiabetic NephropathiesChronickidney functioncomparative studynon insulin dependent diabetes mellitusadultdisease coursearticlerisk assessmentAnemiaGeneral Medicinechronic kidney failureMiddle Agedpriority journalNephrologyCreatininedisease severityFemaleType 2Glomerular Filtration Ratemedicine.medical_specialtyAnaemia diabetes mellitus; Chronic kidney disease diabetes mellitus; Type 2 diabetes mellitus anaemiaRenal functionAnaemiaDiabetes mellitusInternal medicineType 2 diabetes mellitusDiabetes MellitusmedicineHumanscontrolled studyhumanSex DistributionAgedSettore MED/14 - NefrologiaCreatininehemoglobin blood levelbusiness.industrydiabetic nephropathypractice guidelineType 2 Diabetes Mellitusmedicine.diseasemajor clinical studySurgerychemistryDiabetes Mellitus Type 2Kidney Failure ChronicbusinessKidney disease
researchProduct

Pain Phenotypes in Rare Musculoskeletal and Neuromuscular Diseases

2020

For patients diagnosed with a rare musculoskeletal or neuromuscular disease, pain may transition from acute to chronic; the latter yielding additional challenges for both patients and care providers. We assessed the present understanding of pain across a set of ten rare, noninfectious, noncancerous disorders; Osteogenesis Imperfecta, Ehlers-Danlos Syndrome, Achondroplasia, Fibrodysplasia Ossificans Progressiva, Fibrous Dysplasia/McCune-Albright Syndrome, Complex Regional Pain Syndrome, Duchenne Muscular Dystrophy, Infantile- and Late-Onset Pompe disease, Charcot-Marie-Tooth Disease, and Amyotrophic Lateral Sclerosis. Through the integration of natural history, cross-sectional, retrospective…

Neuromuscular diseaseCognitive NeuroscienceDuchenne muscular dystrophyPainDiseaseBioinformaticsArticle03 medical and health sciencesBehavioral Neuroscience0302 clinical medicinemedicineHumans0501 psychology and cognitive sciences050102 behavioral science & comparative psychologyAmyotrophic lateral sclerosisRetrospective Studiesbusiness.industryFibrous dysplasia05 social sciencesNeuromuscular Diseasesmedicine.diseaseCross-Sectional StudiesPhenotypeNeuropsychology and Physiological PsychologyComplex regional pain syndromeOsteogenesis imperfectaFibrodysplasia ossificans progressivabusiness030217 neurology & neurosurgeryNeuroscience & Biobehavioral Reviews
researchProduct

OHADA et COMMON LAW : amis ou ennemis?

2012

The article examines the oHADA law in a comparative perspective, trying to individuate how it can be considered from a common law perspective.

OHADA common law civil law comparative law
researchProduct

The EU’s online gambling regulatory approach and the crisis of legal modernity

2014

ONLINE GAMBLING EU LAW COMPARATIVE LAW INTERNATIONAL CONTRACTS
researchProduct

Mammary olfactory signalisation in females and odor processing in neonates: ways evolved by rabbits and humans

2009

International audience; Mammalian females have long been known to release olfactory attraction in their offspring. Mammary odor cues control infant state, attention and directional responses, delay distress responses, stimulate breathing and positive oral actions, and finally can boost learning. Here, we survey female-offspring odor communication in two mammalian species - European rabbits and humans - taken as representatives of evolutionary extremes in terms of structure and dynamics of mother-infant relations, and level of neonatal autonomy. Despite these early psychobiological differences, females in both species have evolved mammary structures combining multiple sources of endogenous a…

OffspringPheromones HumanContext (language use)Sensory systemOlfactionBiologyPheromones03 medical and health sciencesBehavioral Neurosciencepheromone0302 clinical medicineSpecies Specificityrabbit (Oryctolagus cuniculus)AnimalsHumans0501 psychology and cognitive sciences050102 behavioral science & comparative psychologyhumanMaternal BehaviorComputingMilieux_MISCELLANEOUSInstinctCommunicationmilkbusiness.industryMechanism (biology)[SCCO.NEUR]Cognitive science/Neuroscience05 social sciencesOlfactory PathwaysBiological EvolutionAnimals SucklingBreast FeedingOdorAnimals NewbornOdorantsmother-infant relations[ SCCO.NEUR ] Cognitive science/NeurosciencePheromonePerceptionRabbitsneonatebusinessNeuroscienceBreast feeding030217 neurology & neurosurgeryolfaction
researchProduct

Use of ultrasonic vocalizations to assess olfactory detection in mouse pups treated with 3-methylindole.

2005

International audience; Altricial mammals use olfaction long before the olfactory bulb has reached its anatomically mature state. Indeed, while audition and vision are still not functional, the olfactory system of newborn animals can clearly process distinct odorant molecules. Although several previous studies have emphasized the important role that olfaction plays in early critical functions, it has been difficult to develop a sensitive and reliable test to precisely quantify olfactory ability in pups. One difficulty in determining early sensory capabilities is the rather limited behavioral repertory of neonates. The present study examines the use of ultrasonic vocalizations emitted by iso…

Olfactory systemMale[SDV.NEU.NB]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]/NeurobiologyMESH: UltrasonicsMESH : Behavior AnimalMESH: Animals NewbornBehavioral NeuroscienceMice0302 clinical medicineDiscrimination PsychologicalUltrasound emissionMESH: SmellMESH: Behavior AnimalUltrasonicsMESH: AnimalsMESH: Discrimination (Psychology)OlfactotoxinBehavior AnimalMESH : Animals Newborn05 social sciencesGeneral MedicineMESH : OdorsSkatoleSmellAltricialmedicine.anatomical_structure[ SDV.NEU.NB ] Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]/Neurobiology[SDV.NEU]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]MESH : UltrasonicsMESH : Sensory DeprivationMESH : MaleMESH: Vocalization AnimalMESH: SkatoleSensory systemMESH : Mice Inbred C57BLOlfactionBiologyDevelopment03 medical and health sciencesMESH: Mice Inbred C57BLMESH : MicemedicineAnimals0501 psychology and cognitive sciencesSensory deprivation050102 behavioral science & comparative psychologyMESH: MiceBehaviorMESH: Sensory DeprivationMESH: OdorsMESH : Vocalization AnimalMESH : SkatoleMESH : Discrimination (Psychology)OlfactionMESH: MaleOlfactory bulbMice Inbred C57BLOdorAnimals NewbornOdorantsMESH : SmellAnimal Science and ZoologyMESH : AnimalsSensory DeprivationVocalization AnimalOlfactory epitheliumNeuroscience030217 neurology & neurosurgery
researchProduct

A prospective randomised, open-labeled, trial comparing sirolimus-containing versus mTOR-inhibitor-free immunosuppression in patients undergoing live…

2010

Abstract Background The potential anti-cancer effects of mammalian target of rapamycin (mTOR) inhibitors are being intensively studied. To date, however, few randomised clinical trials (RCT) have been performed to demonstrate anti-neoplastic effects in the pure oncology setting, and at present, no oncology endpoint-directed RCT has been reported in the high-malignancy risk population of immunosuppressed transplant recipients. Interestingly, since mTOR inhibitors have both immunosuppressive and anti-cancer effects, they have the potential to simultaneously protect against immunologic graft loss and tumour development. Therefore, we designed a prospective RCT to determine if the mTOR inhibito…

OncologyCancer ResearchTime Factorsmedicine.medical_treatmentMedizinIntracellular Signaling Peptides and Proteins - antagonists & inhibitors metabolismKaplan-Meier Estimate312 Clinical medicineProtein-Serine-Threonine KinaseLiver transplantationTHERAPYStudy ProtocolImmunosuppressive Agentendothelial growth-factor renal-cell carcinoma tumor progression rapamycin cancer cyclosporine efficacy therapy target model0302 clinical medicineRENAL-CELL CARCINOMARisk FactorsRecurrenceSurgical oncologyMedicine and Health SciencesLiver Neoplasms - drug therapy enzymology mortality surgerySirolimuProspective StudiesTUMOR PROGRESSIONTransplantation Homologoueducation.field_of_studyliver transplantationTOR Serine-Threonine KinasesLiver NeoplasmsIntracellular Signaling Peptides and ProteinsImmunosuppressionhepatocellular carcinomalcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogensCANCER3. Good healthEuropeMulticenter StudyTreatment OutcomeTARGETsirolimusOncologyLiver Neoplasm030220 oncology & carcinogenesisHepatocellular carcinomaRandomized Controlled TrialmTORCarcinoma Hepatocellular - drug therapy enzymology mortality surgery030211 gastroenterology & hepatologyImmunosuppressive AgentsRCTHumanmedicine.drugCanadamedicine.medical_specialtyCarcinoma HepatocellularTime FactoreducationPopulationLiver Transplantation - adverse effects mortalityProtein Serine-Threonine Kinaseslcsh:RC254-282Disease-Free Survival03 medical and health sciencesInternal medicineGeneticsmedicineTransplantation HomologousHumansComparative StudyRapamycinddc:610educationProtein-Serine-Threonine Kinases - antagonists & inhibitors metabolismKaplan-Meiers Estimatebusiness.industryRisk FactorAustraliaImmunosuppressive Agents - therapeutic useSirolimus - therapeutic useEFFICACYHumans; Liver Transplantation; Hepatocellular Carcinoma; Randomized Controlled Trial; RCT; Multicenter Study; Comparative Study; Rapamycin; mTOR; Sirolimusmedicine.diseaseSurgeryMODELTransplantationClinical trialProspective StudieIntracellular Signaling Peptides and ProteinSirolimusENDOTHELIAL GROWTH-FACTORCYCLOSPORINERAPAMYCINbusiness
researchProduct

The presence of genomic imbalances is associated with poor outcome in patients with burkitt lymphoma treated with dose-intensive chemotherapy includi…

2015

Part of this study has been reported as an oral presentation at the EHA Meeting in Vienna 2015.

OncologyMalemedicine.medical_treatmentarray-based comparative genomic hybridization (aCGH)Intensive chemotherapyKaplan-Meier EstimateBioinformatics0302 clinical medicinerituximabAntineoplastic Combined Chemotherapy ProtocolsYoung adultComparative Genomic HybridizationGenomeArray-based comparative genomic hybridizationBurkitt lymphomaHigh-Throughput Nucleotide SequencingHematologyMiddle AgedPrognosisBurkitt Lymphomahumanities3. Good healthTreatment Outcome030220 oncology & carcinogenesisoutcomeRituximabFemaleRituximabmedicine.drugAdultmedicine.medical_specialtyAdolescenteducationBiologyNext-generation sequencing outcome03 medical and health sciencesYoung AdultInternal medicinemedicineHumansIn patientAgedChromosome AberrationsChemotherapymedicine.diseaseGNA13Lymphomastomatognathic diseasesnext-generation sequencing030215 immunologyComparative genomic hybridization
researchProduct